Evidence map›Paper›PMID 33295836›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

E-cigarettes and health risks: more to the flavor than just the name.

M P Ween, A Moshensky, L Thredgold, N A Bastian, R Hamon, A Badiei, P T Nguyen, K Herewane, H Jersmann, C M Bojanowski and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pulmonary effects of e-liquid flavors: a systematic review.Journal of toxicology and environmental health. Part B, Critical reviews · 2022
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Memory under siege: the cognitive costs of smoking and vaping.Brain, behavior, & immunity - health · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. E-Cigarette Vapour Increases ACE2 and TMPRSS2 Expression in a Flavour- and Nicotine-Dependent Manner.International journal of environmental research and public health · 2022
    Article
  19. Electronic Cigarettes: A Pro-Con Review of the Current Literature.The journal of allergy and clinical immunology. In practice · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

M P WeenDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.ORCID 0000-0002-0600-4585
A MoshenskyPulmonary Critical Care Section, Veterans Affairs San Diego Healthcare System, San Diego, California.
L ThredgoldDepartment of Occupational and Environmental Health, School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
N A BastianDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
R HamonDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
A BadieiDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
P T NguyenDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
K HerewaneDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
H JersmannDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
C M BojanowskiPulmonary Critical Care Section, Veterans Affairs San Diego Healthcare System, San Diego, California.
J ShinPulmonary Critical Care Section, Veterans Affairs San Diego Healthcare System, San Diego, California.
P N ReynoldsDepartment of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
L E Crotty AlexanderPulmonary Critical Care Section, Veterans Affairs San Diego Healthcare System, San Diego, California.ORCID 0000-0002-5091-2660
S J HodgeSchool of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Royal Adelaide Hospital · AUUniversity of California System · USThe University of Adelaide · AUSouth Australia Pathology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing interest in regulating flavored E-liquids must incorporate understanding of the "flavoring profile" of each E-liquid-which flavorings (flavoring chemicals) are present and at what concentrations not just focusing on the flavor on the label. We investigated the flavoring profile of 10 different flavored E-liquids. We assessed bronchial epithelial cell viability and apoptosis, phagocytosis of bacteria and apoptotic cells by macrophages after exposure to E-cigarette vapor extract (EVE). We validated our data in normal human bronchial epithelial cells (NHBE) and alveolar macrophages (AM) from healthy donors. We also assessed cytokine release and validated in the saliva from E-cigarette users. Increased necrosis/apoptosis (16.1-64.5% apoptosis) in 16HBE cells was flavor dependent, and NHBEs showed an increased susceptibility to flavors. In THP-1 differentiated macrophages phagocytosis was also flavor dependent, with AM also showing increased susceptibility to flavors. Further, Banana and Chocolate were shown to reduce surface expression of phagocytic target recognition receptors on alveolar macrophages. Banana and Chocolate increased IL-8 secretion by NHBE, whereas all 4 flavors reduced AM IL-1β secretion, which was also reduced in the saliva of E-cigarette users compared with healthy controls. Flavorant profiles of E-liquids varied from simple 2 compound mixtures to complex mixtures containing over a dozen flavorants. E-liquids with high benzene content, complex flavoring profiles, high chemical concentration had the greatest impacts. The Flavorant profile of E-liquids is key to disruption of the airway status quo by increasing bronchial epithelial cell apoptosis, causing alveolar macrophage phagocytic dysfunction, and altering airway cytokines.

Indexed as

ApoptosisPhagocytosisBronchiCytokinesElectronic Nicotine Delivery SystemsFlavoring AgentsHumansMacrophagesRisk FactorsCytokinesFlavoring Agentscytokinee-cigaretteflavormacrophage

Identifiers

PMID33295836
PMCPMC8424560
OpenAlexW3113003848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.